PPARG and nasopharyngeal carcinoma: Intriguingly, PPARγ expression evaluated by GEO datasets (GSE2658 and GSE5900) showed significant downregulation of PPARγ in 559 MM patients compared with those in the NPC (normal people) and MGUS patients (Figure 3E).